Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans Health | 1 | 2023 | 1 | 0.860 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2020 | 11 | 0.690 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 27 | 0.670 |
Why?
|
| Anticoagulants | 1 | 2020 | 57 | 0.660 |
Why?
|
| African Americans | 2 | 2018 | 47 | 0.610 |
Why?
|
| Transportation | 1 | 2017 | 7 | 0.580 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 31 | 0.560 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 280 | 0.470 |
Why?
|
| Aged | 6 | 2024 | 1740 | 0.340 |
Why?
|
| Middle Aged | 10 | 2024 | 3601 | 0.340 |
Why?
|
| Terminal Care | 2 | 2020 | 35 | 0.320 |
Why?
|
| Humans | 19 | 2024 | 14537 | 0.320 |
Why?
|
| Male | 12 | 2024 | 6754 | 0.290 |
Why?
|
| Neoplasms | 2 | 2020 | 147 | 0.280 |
Why?
|
| United States | 2 | 2023 | 132 | 0.250 |
Why?
|
| Hospitalization | 3 | 2024 | 418 | 0.240 |
Why?
|
| Hospitals | 2 | 2023 | 103 | 0.220 |
Why?
|
| Community-Acquired Infections | 1 | 2024 | 102 | 0.220 |
Why?
|
| Prospective Studies | 3 | 2024 | 1160 | 0.210 |
Why?
|
| Adult | 11 | 2024 | 5913 | 0.210 |
Why?
|
| Bronchial Arteries | 1 | 2002 | 1 | 0.200 |
Why?
|
| Thoracic Arteries | 1 | 2002 | 1 | 0.200 |
Why?
|
| Hemoptysis | 1 | 2002 | 4 | 0.200 |
Why?
|
| Embolization, Therapeutic | 1 | 2002 | 4 | 0.200 |
Why?
|
| Palliative Care | 2 | 2020 | 52 | 0.190 |
Why?
|
| Pneumococcal Vaccines | 1 | 2024 | 278 | 0.190 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 32 | 0.180 |
Why?
|
| Female | 9 | 2024 | 9103 | 0.170 |
Why?
|
| Environment, Controlled | 1 | 2020 | 1 | 0.170 |
Why?
|
| Equipment Contamination | 1 | 2020 | 5 | 0.170 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 16 | 0.170 |
Why?
|
| Betacoronavirus | 1 | 2020 | 52 | 0.170 |
Why?
|
| Guideline Adherence | 1 | 2020 | 43 | 0.170 |
Why?
|
| Time Factors | 2 | 2017 | 507 | 0.160 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 411 | 0.160 |
Why?
|
| Arthroplasty, Replacement | 1 | 2018 | 1 | 0.160 |
Why?
|
| Eligibility Determination | 1 | 2018 | 16 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 71 | 0.160 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 14 | 0.150 |
Why?
|
| Terminally Ill | 1 | 2018 | 21 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 104 | 0.150 |
Why?
|
| Patient Preference | 1 | 2018 | 30 | 0.150 |
Why?
|
| Risk Factors | 5 | 2024 | 1475 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 43 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 239 | 0.150 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2017 | 7 | 0.150 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2024 | 100 | 0.150 |
Why?
|
| Geographic Information Systems | 1 | 2017 | 6 | 0.150 |
Why?
|
| Pandemics | 1 | 2020 | 296 | 0.140 |
Why?
|
| Scleroderma, Systemic | 1 | 2017 | 43 | 0.140 |
Why?
|
| Tuberculosis | 3 | 2008 | 543 | 0.140 |
Why?
|
| Referral and Consultation | 2 | 2006 | 57 | 0.130 |
Why?
|
| South Africa | 9 | 2024 | 7596 | 0.120 |
Why?
|
| Endocarditis | 1 | 2013 | 4 | 0.110 |
Why?
|
| Mitral Valve | 1 | 2013 | 12 | 0.110 |
Why?
|
| Rheumatic Heart Disease | 1 | 2013 | 13 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1422 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2011 | 4 | 0.100 |
Why?
|
| Colony Count, Microbial | 1 | 2011 | 14 | 0.100 |
Why?
|
| Aneurysm | 1 | 2011 | 3 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 90 | 0.090 |
Why?
|
| Streptococcus pneumoniae | 1 | 2011 | 336 | 0.080 |
Why?
|
| Odds Ratio | 2 | 2018 | 133 | 0.070 |
Why?
|
| HIV Infections | 2 | 2024 | 5097 | 0.070 |
Why?
|
| Logistic Models | 2 | 2018 | 254 | 0.070 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2009 | 200 | 0.070 |
Why?
|
| Lactobacillus casei | 1 | 2005 | 1 | 0.060 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 1 | 0.060 |
Why?
|
| Cell Extracts | 1 | 2005 | 3 | 0.060 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2005 | 17 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 14 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2009 | 374 | 0.060 |
Why?
|
| Hospitals, Special | 1 | 2005 | 4 | 0.060 |
Why?
|
| Antitubercular Agents | 1 | 2008 | 322 | 0.060 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2008 | 329 | 0.060 |
Why?
|
| Incidence | 1 | 2024 | 685 | 0.050 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2005 | 324 | 0.050 |
Why?
|
| Angiography | 1 | 2002 | 6 | 0.050 |
Why?
|
| Bronchiectasis | 1 | 2002 | 11 | 0.050 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2021 | 17 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2021 | 30 | 0.050 |
Why?
|
| Consensus | 1 | 2021 | 62 | 0.050 |
Why?
|
| Urban Health | 1 | 2021 | 78 | 0.040 |
Why?
|
| Bedding and Linens | 1 | 2020 | 2 | 0.040 |
Why?
|
| Patient Isolation | 1 | 2020 | 5 | 0.040 |
Why?
|
| Anti-Retroviral Agents | 1 | 2024 | 551 | 0.040 |
Why?
|
| Spirituality | 1 | 2020 | 11 | 0.040 |
Why?
|
| Pain | 1 | 2020 | 41 | 0.040 |
Why?
|
| Minority Groups | 1 | 2018 | 4 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2002 | 889 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 13 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2018 | 10 | 0.040 |
Why?
|
| Quality of Life | 1 | 2020 | 177 | 0.040 |
Why?
|
| Protective Factors | 1 | 2017 | 7 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 20 | 0.040 |
Why?
|
| Young Adult | 1 | 2024 | 2498 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2017 | 64 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 171 | 0.040 |
Why?
|
| Prognosis | 1 | 2017 | 199 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 253 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 221 | 0.030 |
Why?
|
| Child | 3 | 2008 | 2242 | 0.030 |
Why?
|
| Viral Load | 1 | 2020 | 819 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2017 | 799 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 2244 | 0.030 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 5 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 63 | 0.030 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2011 | 2 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2011 | 2 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2011 | 23 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 61 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 217 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2011 | 151 | 0.020 |
Why?
|
| Comorbidity | 1 | 2009 | 188 | 0.020 |
Why?
|
| Gastric Juice | 1 | 2008 | 6 | 0.020 |
Why?
|
| Adolescent | 2 | 2006 | 2985 | 0.020 |
Why?
|
| Sputum | 1 | 2008 | 135 | 0.020 |
Why?
|
| Hospitals, District | 1 | 2006 | 5 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2005 | 1 | 0.020 |
Why?
|
| Cell Wall | 1 | 2005 | 9 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 45 | 0.020 |
Why?
|
| Mice | 1 | 2005 | 135 | 0.020 |
Why?
|
| Medical Records | 1 | 2005 | 23 | 0.020 |
Why?
|
| Hospitals, Public | 1 | 2005 | 45 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2005 | 120 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 203 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2005 | 195 | 0.010 |
Why?
|
| Animals | 1 | 2005 | 1081 | 0.010 |
Why?
|